Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed vs Pemetrexed + Carboplatin in Second-Line Advanced NSCLC
NCT00786331Phase 2Unknown
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Jul 2007
- Primary completion
- Jul 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in non-small cell lung cancer (NSCLC), sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Status: unknown.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00786331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786331.